AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 87 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $11,406,000 | -15.5% | 1,670,000 | 0.0% | 0.21% | -9.6% |
| Q4 2021 | $13,494,000 | -39.5% | 1,670,000 | -26.6% | 0.23% | -34.3% |
| Q3 2021 | $22,295,000 | -24.1% | 2,275,000 | -47.9% | 0.35% | -31.5% |
| Q2 2021 | $29,376,000 | -25.6% | 4,365,000 | 0.0% | 0.51% | -25.0% |
| Q1 2021 | $39,460,000 | +35.3% | 4,365,000 | 0.0% | 0.68% | +35.7% |
| Q4 2020 | $29,158,000 | +37.7% | 4,365,000 | +3.9% | 0.50% | +66.8% |
| Q3 2020 | $21,168,000 | -42.6% | 4,200,000 | -8.0% | 0.30% | -58.7% |
| Q2 2020 | $36,890,000 | +6.4% | 4,565,655 | +4.6% | 0.73% | -37.7% |
| Q1 2020 | $34,663,000 | – | 4,365,655 | – | 1.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 985,210 | $10,345,000 | 6.10% |
| Broadfin Capital, LLC | 3,568,122 | $37,465,000 | 5.54% |
| JW Asset Management, LLC | 444,439 | $4,667,000 | 3.42% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $17,724,000 | 2.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $38,383,000 | 1.73% |
| FALCON POINT CAPITAL, LLC | 661,490 | $6,284,000 | 0.91% |
| KNOTT DAVID M | 158,555 | $1,665,000 | 0.71% |
| Perceptive Advisors | 3,098,010 | $32,530,000 | 0.62% |
| Sio Capital Management, LLC | 91,413 | $960,000 | 0.50% |
| HEARTLAND ADVISORS INC | 700,000 | $7,350,000 | 0.48% |